BamSEC and AlphaSense Join Forces
Learn More

Alaunos Therapeutics Inc.

NASDAQ: TCRT    
Share price (12/24/24): $1.96    
Market cap (12/24/24): $3.138 million
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.6
from S-3 20 pages Alaunos Therapeutics, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Alaunos Therapeutics, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.5
from S-3 22 pages Alaunos Therapeutics, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Alaunos Therapeutics, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3 21 pages Alaunos Therapeutics, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Alaunos Therapeutics, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.2
from S-3 54 pages Alaunos Therapeutics, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20 Debt Securities
12/34/56
EX-4.7
from 10-K 4 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.6
from 10-K 12 pages Amended and Restated Warrant to Purchase Stock
12/34/56
EX-4.1
from 10-Q 12 pages Warrant to Purchase Stock
12/34/56
EX-4.8
from 10-K 3 pages Description of the Registrant’s Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
12/34/56
EX-4.7
from 10-K 15 pages Certain Confidential Information Contained in This Document, Marked by [*****], Has Been Omitted Because Ziopharm Oncology, Inc. Has Determined the Information (I) Is Not Material and (II) Would Likely Cause Competitive Harm to Ziopharm Oncology, Inc. if Publicly Disclosed
12/34/56
EX-4.1
from 8-K 13 pages Ziopharm Oncology, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.1
from 8-K 14 pages Ziopharm Oncology, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.7
from S-3ASR 18 pages Ziopharm Oncology, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Ziopharm Oncology, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3ASR 20 pages Ziopharm Oncology, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Ziopharm Oncology, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.5
from S-3ASR 20 pages Ziopharm Oncology, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Ziopharm Oncology, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.3
from S-3ASR 55 pages Ziopharm Oncology, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [•], 20 Debt Securities
12/34/56
EX-4.1
from 8-K 13 pages Ziopharm Oncology, Inc. Warrant to Purchase Common Stock
12/34/56
EX-4.7
from S-3ASR 17 pages Ziopharm Oncology, Inc. and , as Warrant Agent Form of Debt Securities Warrant Agreement Dated as of Ziopharm Oncology, Inc. Form of Debt Securities Warrant Agreement
12/34/56
EX-4.6
from S-3ASR 17 pages Ziopharm Oncology, Inc. and , as Warrant Agent Form of Preferred Stock Warrant Agreement Dated as of Ziopharm Oncology, Inc. Form of Preferred Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.5
from S-3ASR 17 pages Ziopharm Oncology, Inc. and , as Warrant Agent Form of Common Stock Warrant Agreement Dated as of Ziopharm Oncology, Inc. Form of Common Stock Warrant Agreement Article 1 Issuance of Warrants and Execution and Delivery of Warrant Certificates
12/34/56
EX-4.4
from S-3ASR 41 pages Ziopharm Oncology, Inc., Issuer and [Trustee], Trustee Indenture Dated as of [—], 20 Debt Securities
12/34/56